PULMATRIX INC (PULM)
US74584P3010 - Common Stock
PULM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 198 industry peers in the Pharmaceuticals industry. The financial health of PULM is average, but there are quite some concerns on its profitability. PULM shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year PULM has reported negative net income.
In the past year PULM has reported a negative cash flow from operations.
In the past 5 years PULM always reported negative net income.
In the past 5 years PULM reported 4 times negative operating cash flow.
1.2 Ratios
PULM has a Return On Assets of -41.59%. This is comparable to the rest of the industry: PULM outperforms 46.67% of its industry peers.
Looking at the Return On Equity, with a value of -78.48%, PULM is in line with its industry, outperforming 45.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.59% | ||
| ROE | -78.48% | ||
| ROIC | N/A |
ROA(3y)-42.44%
ROA(5y)-47.01%
ROE(3y)-62.76%
ROE(5y)-91.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for PULM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PULM does not have a ROIC to compare to the WACC, probably because it is not profitable.
PULM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PULM has been increased compared to 5 years ago.
There is no outstanding debt for PULM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -12.19, we must say that PULM is in the distress zone and has some risk of bankruptcy.
PULM's Altman-Z score of -12.19 is on the low side compared to the rest of the industry. PULM is outperformed by 77.95% of its industry peers.
There is no outstanding debt for PULM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.19 |
ROIC/WACCN/A
WACC9.34%
2.3 Liquidity
A Current Ratio of 5.33 indicates that PULM has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.33, PULM is doing good in the industry, outperforming 68.72% of the companies in the same industry.
A Quick Ratio of 5.33 indicates that PULM has no problem at all paying its short term obligations.
The Quick ratio of PULM (5.33) is better than 70.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.33 | ||
| Quick Ratio | 5.33 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.30% over the past year.
The Revenue has grown by 20.13% in the past year. This is a very strong growth!
The Revenue has been growing by 117.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.3%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)20.13%
Revenue growth 3Y-16.71%
Revenue growth 5Y117.48%
Revenue growth Q2Q28.77%
3.2 Future
Based on estimates for the next years, PULM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.73% on average per year.
PULM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.85% yearly.
EPS Next Y-18.91%
EPS Next 2Y-14.37%
EPS Next 3Y12.08%
EPS Next 5Y22.73%
Revenue Next Year1%
Revenue Next 2Y1%
Revenue Next 3Y33.81%
Revenue Next 5Y40.85%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PULM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PULM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PULM's earnings are expected to grow with 12.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.37%
EPS Next 3Y12.08%
5. Dividend
5.1 Amount
No dividends for PULM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PULMATRIX INC
NASDAQ:PULM (4/26/2024, 7:11:53 PM)
After market: 1.9544 -0.09 (-4.2%)2.04
-0.04 (-1.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.45M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.59% | ||
| ROE | -78.48% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.33 | ||
| Quick Ratio | 5.33 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)29.3%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-18.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.13%
Revenue growth 3Y-16.71%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y